Wegovy pen volume in ml: what the numbers actually mean

Where the 1.5 ml figure comes from, and why the pen's volume doesn't change

The Wegovy pen is a pre-filled, disposable auto-injector. Its cartridge holds exactly 1.5 ml of clear, colourless solution, a volume that was set during the medicine's development to suit the subcutaneous injection route and to keep the pen a practical size. What varies across the dose range is the concentration of semaglutide per ml. A 0.25 mg pen delivers that dose from 1.5 ml of a low-concentration solution; a 2.4 mg pen draws on 1.5 ml of a much higher-concentration formulation. The volume you inject is identical either way.

This matters practically because questions like "how much liquid goes in?" sometimes come from people who are new to injections and find the sensation unexpectedly mild. The 1.5 ml is given subcutaneously (into the fatty tissue just below the skin at the abdomen, thigh or upper arm) and most people barely notice it. The pen mechanism handles the depth and speed automatically. How the Wegovy pen works is worth reading before your first injection if the mechanics feel unfamiliar.

The NHS medicines page for semaglutide sets out the injection method and what to expect in straightforward language. One detail worth noting from that guidance: rotate injection sites with each dose to avoid skin changes at any single spot. Always follow the Patient Information Leaflet that arrives with your pen for the definitive instructions.

The 1 ml pen versus the 1.5 ml pen: which one you'll receive

Not all Wegovy pens hold 1.5 ml. The 0.25 mg and 0.5 mg starting doses are supplied in a 1 ml pen. From 1 mg upwards, the pen format switches to 1.5 ml. This is a manufacturing and concentration decision by Novo Nordisk, not a clinical one, the prescribed dose remains the primary fact; the pen format follows automatically.

In practice this means people sometimes receive differently sized pens at different points in their treatment. Both are used in exactly the same way. If you want to understand the exact format for the lower doses, the 1 ml Wegovy pen guide explains the starting-dose presentations specifically. The full breakdown of ml volumes across the Wegovy range sets out the complete picture by strength, which can be useful for storage and travel planning.

For cost context (because pen format sometimes comes up on price comparison discussions) the Wegovy cost in the UK page explains how private pricing works and what legitimate treatment includes beyond the pen itself.

Discarding the pen after use

Each pen is single-use. Once the dose is given, the needle must be removed and disposed of in an approved sharps container, standard household bins are not suitable for used needles in the UK. A 1-litre sharps container is the right size for most people using weekly injections at home, and local councils typically offer collection or drop-off. The empty pen body (without needle) goes in the household waste.

Needle-change discipline matters for a different reason too: always attach a fresh needle immediately before injecting and remove it straight afterwards. Leaving a needle attached can allow air to enter the cartridge and affect dose accuracy. If you need replacement needles, packs of 100 compatible needles are available. Clean the injection site with an alcohol swab beforehand and let it dry completely before inserting the needle.

When a Wegovy pen arrives from our pharmacy, it comes via DPD with a tracking notification to your phone, in plain unbranded packaging, with the cold-chain maintained. The pen itself is sealed in its manufacturer's blister tray, with the Patient Information Leaflet and a needle already included in the box for most presentations. Read that leaflet before the first dose, it is the authoritative guide on administration and storage windows for that specific strength.

What the pen volume can't tell you: suitability and dose

Knowing that a Wegovy pen contains 1.5 ml is useful context, but it settles nothing about whether Wegovy is the right choice for a given person or which dose to start on. That decision rests on a clinical assessment. Semaglutide (Wegovy) is licensed for adults with a BMI of 30 or above, or 27–29.9 alongside a weight-related health condition such as hypertension or high cholesterol, a prescriber assesses the whole picture, not the BMI alone.

The titration schedule is set by NICE guidance and the medicine's SmPC. A prescriber starts treatment at the lowest tolerable dose and adjusts upward over months, reviewing how the patient is responding. No part of that process is determined by the pen's volume. It is worth reading about the Wegovy treatment overview if you want a broader picture of how the medicine is used, or exploring weight-loss treatment options more generally if you are still deciding which route suits your situation.

NICE's recommendation for semaglutide (published as NICE technology appraisal TA875) covers NHS eligibility criteria in detail. Private treatment follows the licensed indications in the SmPC, and a prescriber at a regulated pharmacy like ours applies those criteria independently. If you are ready to find out whether you qualify, check your eligibility through a free consultation with our clinical team.